Dec 13, 2017

T-Mobile jumps into digital TV with Layer3 acquisition

AP Photo/Hermann J. Knippertz

T-Mobile, which has risen to become the nation's third-largest wireless provider, is buying digital cable startup Layer3 TV to launch a nationwide digital internet-TV service in 2018, the company announced Wednesday.

Why it matters: T-Mobile joins AT&T and Verizon in launching its own video service, creating another challenger to traditional cable and satelite TV providers, which have been losing pay-TV subscribers as they migrate towards cheaper, digital options.

  • T-Mobile has been pushing to stay compeitive in the race for wireless consumers for years through partnerships with Netflix and unlimited data offerings. The company discussed a merger with Sprint earlier this year, but talks fell through after neither company could decide which entity would take majority stake in the merger.
  • The announcement falls in line with T-Mobile's pitch that it is a more consumer-friendly option than big cable proviers like AT&T and Verizon. Layer3's bundle does not look the same as some of the other "skinny bundles" out there, like AT&T's DirectTV or Dish' Sling. It's pricer, but offers more digital HD channels (275), as well as high-end DVR capabitilies and access to other digital apps.
  • T-Mobile executives also stressed how much it values relationships with content providers, saying there are "no holes" in its relationships with content providers on a call with reporters and investors Wednesday. (Pay-TV providers and TV networks have been increasingly getting in fights over the cost of programming, which affects consumers' access to programming.)

Go deeper

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 5,453,784 — Total deaths: 345,886 — Total recoveries — 2,191,310Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 1,651,254 — Total deaths: 97,850 — Total recoveries: 366,736 — Total tested: 14,163,915Map.
  3. World: Top Boris Johnson aide defends himself after allegations he broke U.K. lockdown — WHO suspends trial of hydroxychloroquine over safety concerns.
  4. 2020: Trump threatens to move Republican convention from North Carolina — Joe Biden makes first public appearance in two months.
  5. Public health: Officials are urging Americans to wear masks over Memorial Day.
  6. Economy: White House economic adviser Kevin Hassett says it's possible the unemployment rate could still be in double digits by November's election — Charities refocus their efforts to fill gaps left by government.
  7. What should I do? Hydroxychloroquine questions answeredTraveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 53 mins ago - Politics & Policy

Joe Biden makes first public appearance in over two months

Photo: Oliver Douliery/AFP via Getty Images

Former Vice President Joe Biden made his first in-person appearance in over two months on Monday to honor Memorial Day by laying a wreath at a Delaware veterans park, AP reports.

Why it matters: Biden, the Democratic Party's presumptive nominee, has taken the unprecedented step of campaigning from his home during the coronavirus pandemic, ever since canceling a rally in Cleveland on March 10.

WHO temporarily suspends trial of hydroxychloroquine over safety concerns

Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization is temporarily pausing tests of the anti-malarial drug hydroxychloroquine as a coronavirus treatment in order to review safety concerns, the agency's director-general Tedros Adhanom Ghebreyesu said Monday.

Why it matters: The decision comes after a retrospective review published in The Lancet found that coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing.